Manufacturer record
Lifevision Healthcare: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
10 batches manufactured by Lifevision Healthcare (Himachal Pradesh) were declared Not of Standard Quality between July 2021 and February 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: LSG-3892, Calcitriol, Calcium Citrate Malate, Vitamin K2-7, Methylcobalamin, Zinc, Magnesium & L-Methyl Folate Soft Gelatin Capsules (exp Jun 2026). CDL, Kolkata (CDSCO lab) found it not of standard quality: The sample does not conform to claim as per Schedule V Drugs.and Cosmetics Act !940 with respect to Assay of Zinc Oxide and L-Methylfolate. Listed in the February 2026 alert.
Records by type
10 records linked to Lifevision Healthcare in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Calcitriol, Calcium Citrate Malate, Vitamin K2-7, Methylcobalamin, Zinc, Magnesium & L-Methyl Folate Soft Gelatin Capsules | Batch LSG-3892Mfg Jan 2025 · Exp Jun 2026 | The sample does not conform to claim as per Schedule V Drugs.and Cosmetics Act !940 with respect to Assay of Zinc Oxide and L-Methylfolate Calcium.Assay | CDL, KolkataCDSCO lab | Feb 2026 |
| Calcium Carbonate, Vitamin D3, Magnesium & Zinc Sulphate Tablets | Batch LTA-45710Mfg Nov 2024 · Exp Apr 2026 | The sample does not conform to claim as per Manufacturer's Specification with respect to the Assay of Zinc Sulphate Monohydrate equivalent to elemental Zinc.Assay | CDL, KolkataCDSCO lab | Jan 2026 |
| Calcium Carbonate Vitamin D3, Magnesium & Zinc Sulphate Tablets | Batch LTA-47700Mfg Apr 2025 · Exp Sep 2026 | The sample does not conform to the claim with respect to Assay of Vitamin D3 and Elemental Zinc.Assay | DTL JaipurState lab | Jan 2026 |
| Dextromethorphan HBr, Phenylephrine HCI & CPM Syrup(Koff-Max D) | Batch LLD-8030Mfg May 2024 · Exp Apr 2026 | ContentOther | Drugs Testing Laboratory, Madurai-19State lab | Dec 2025 |
| Ribzyl 40 LS | Batch LTA-45608Mfg Nov 2024 · Exp Oct 2026 | Failing in Description of Tablets.Description | Drug Testing Laboratory Dalgate, Jammu and KashmirState lab | Jul 2025 |
| Rabeprazole Sodium 20mg (EC) & Domperidone 10mg (IR), Domperidone 20mg (SR) Capsules (Rebast-ARD) | Batch LC-6943Mfg Jan 2024 · Exp Dec 2025 | DissolutionDissolution | RDTL GuwahatiCDSCO lab | Jan 2025 |
| Synetivit Capsules (Omega-3 Fatty Acid, Green Tea Extract, Ginkgo Biloba, Ginseng, Grape Seeds Extract, Vitamins, Minerals & Trace Elements Soft Gelatin Capsules) | Batch LSG-2890Mfg Jul 2023 · Exp Dec 2024 | Disintegration, Assay of Lactic Acid Bacillus, Vitamin B6, Folic Acid & NiacinamideAssay | CDL KolkataCDSCO lab | Jul 2024 |
| Airmol�-650 Tablets (Paracetamol Dispersible Tablets BP 650 mg) | Batch LTA-20967Mfg Dec 2021 · Exp Nov 2024 | Fineness of dispersion and DisintegrationDisintegration | RDTL GuwahatiState lab | Oct 2022 |
| Rabeprazole Sodium Gastro Resistant Tablets IP (RABGIO-20) | Batch LTA-7123Mfg Apr 2020 · Exp Mar 2022 | DissolutionDissolution | RDTL GuwahatiState lab | Jul 2021 |
| Calcium & Vitamin D3 Tablets I.P. (CALGIO-D3) | Batch LTA-6957Mfg Mar 2020 · Exp Aug 2021 | Assay of Vitamin D3Assay | RDTL GuwahatiState lab | Jul 2021 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.